Skip to content
Research Article Open access CC BY 4.0

Burden of Malaria and Prospective Challenges in South-East Asia Region: A Review

Amit Bhattacharya, Neetu Bharti

International Journal of TROPICAL DISEASE & Health · pp. 1–7 · Published 28 May 2015

10.9734/IJTDH/2015/18502

Abstract

Malaria caused 350 to 500 million clinical episodes in the year 2000 and remains the fifth most deadly infectious disease worldwide after respiratory infections, HIV/AIDS, diarrhoeal diseases, and tuberculosis. Though malaria remains a global health concern in developing nations, the approximate malaria-infected cases reduced from 227 million cases in 2000 to 198 million cases in 2013 globally. Notably in Africa over the last decades, malaria eradication programmes have received greater international attention leading to reduction of parasite-infected cases by 26%, with a decrease in cases from 173 million in 2000 to 128 million in 2013. Nevertheless malaria remains a global health concern in developing nations. The World Health Organization (WHO) South-East Asia Region (SEAR) comprises of 11 member states (Bangladesh, Bhutan, Democratic People's Republic of Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, Timor-Leste) of which 10 countries are malaria endemic while Maldives has been declared malaria-free nation since 1984. Presently no licensed malaria vaccine is available and vaccine developers are working on several novel approaches to make a breakthrough as these vaccines would probably be crucial factor to prevent the transmission and onset of malaria. Further due to excessive dependence on artemisinin-based combination therapy (ACTs), emergence of drug resistant parasites, malaria co-infection in immunocompromised patients and newer P. knowlesi strains are fuelling this severe public health problem. Effective measures such as routine surveillance of the antimalarial drug efficacy, newer rapid diagnostic tools (RDTs) and appropriate treatment regimes will help to monitor and limit this deadly disease especially in the malaria-endemic countries. In this review, the various intertwined factors leading to malaria burden – a continuing problem for global health- specially in South-East Asia region are highlighted.

Malarial parasite Plasmodium knowlesi HIV-malaria coinfection artemisinin resistance.

References (18)

  1. 1 A molecular marker of artemisinin-resistant Plasmodium falciparum malaria [DOI]
  2. 2 A large focus of naturally acquired Plasmodium knowlesi infections in human beings [DOI]
  3. 3 Plasmodium knowlesi Malaria in Humans Is Widely Distributed and Potentially Life Threatening [DOI]
  4. 4 Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa [DOI]
  5. 5 Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study [DOI]
  6. 6 Plasmodium knowlesi: The Fifth Human Malaria Parasite [DOI]
  7. 7 Knowlesi malaria: newly emergent and of public health importance? [DOI]
  8. 8 Naturally AcquiredPlasmodium knowlesiMalaria in Human, Thailand [DOI]
  9. 9 Morphological features and differential counts of Plasmodium knowles i parasites in naturally acquired human infections [DOI]
  10. 10 Efficacy of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010 [DOI]
  11. 11 Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai–Myanmar Border, 1999–2011: An Observational Study [DOI]
  12. 12 Improved performance with saliva and urine as alternative DNA sources for malaria diagnosis by mitochondrial DNA-based PCR assays [DOI]
  13. 13 A Study of Monkey-Malaria, and Its Experimental Transmission to Man.
  14. 14 Malaria elimination in iran, importance and challenges.
  15. 15 Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence [DOI]
  16. 16 The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis [DOI]
  17. 17 HIV Protease Inhibitors, Indinavir or Nelfinavir, Augment Antimalarial Action of Artemisinin in vitro [DOI]
  18. 18 Chemotherapy and drug resistance status of malaria parasite in northeast India [DOI]

Cited by 1

Smokeless Tobacco and Stroke - A Clinico-epidemiological Follow-up Study in A Tertiary Care Hospital.

Subhransu Jena, Shobhitendu Kabi, B. Panda · Journal of clinical and diagnostic research : JCDR · 2016

Related research

Article metrics

Real usage data collected on this platform.

1

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.